Bypassing HPDL blockade, headgroup precursors 4-HMA/4-HB reactivate endogenous CoQ10 synthesis, restoring mitochondrial energetics and reversing neurodegeneration where exogenous CoQ10 failsâ€”a brain-penetrant strategy that treats CoQ10 deficiency not by supplementation but by reconstituting its endogenous biosynthetic pathway.